How Long Has Cimzia Been on the Market?

Cimzia (certolizumab pegol) is a biologic medication that has been used to treat Crohn’s disease, ulcerative colitis, and rheumatoid arthritis since its approval by the FDA in 2008. The medication works by targeting and binding to a protein called TNF-alpha, which is involved in inflammatory conditions such as Crohn’s disease. Cimzia is typically given as an injection every 4 weeks, and can be used in conjunction with other medications to achieve the best possible outcome for the patient.

Crohn’s disease is a chronic inflammatory condition of the digestive tract that can lead to a number of serious complications, including intestinal bleeding, weight loss, and malnutrition. Cimzia works by targeting and binding to TNF-alpha, which is a protein involved in the inflammatory process. By binding to this protein, cimzia is able to help reduce the inflammation associated with Crohn’s disease and improve the symptoms of the condition.

Ulcerative colitis is another chronic inflammatory condition that affects the digestive tract. Like Crohn’s disease, ulcerative colitis can lead to a number of serious complications, including intestinal bleeding, weight loss, and malnutrition. Cimzia works by targeting and binding to TNF-alpha, which is a protein involved in the inflammatory process. By binding to this protein, cimzia is able to help reduce the inflammation associated with ulcerative colitis and improve the symptoms of the condition.

Rheumatoid arthritis is a chronic inflammatory condition that affects the joints. The inflammation associated with rheumatoid arthritis can lead to joint damage, pain, and disability. Cimzia works by targeting and binding to TNF-alpha, which is a protein involved in the inflammatory process. By binding to this protein, cimzia is able to help reduce the inflammation associated with rheumatoid arthritis and improve the symptoms of the condition.

Cimzia is a biologic medication that has been proven to be effective in the treatment of Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. Cimzia works by targeting and binding to TNF-alpha, which is a protein involved in the inflammatory process. By binding to this protein, cimzia is able to help reduce the inflammation associated with

Cimzia (certolizumab pegol) is a prescription medicine used to treat:

Rheumatoid arthritis (RA). Cimzia is used alone or with other medicines to reduce the signs and symptoms of RA, to prevent further damage to your bones and joints, and to improve your ability to perform daily activities.

Crohn’s disease (CD). Cimzia is used in adults to help reduce the number of times you need to go to the bathroom, the number of minerals and liquid you lose from your body, and the number of episodes of seen blood in your stool. Cimzia can also help heal damage to your intestine, and improve your quality of life.

Cimzia is aDMARD (anti-TNF biologic). It works by blocking the action of TNF, a protein that causes inflammation in the body.

Cimzia comes as a pre-filled syringe or prefilled pen to inject under the skin. It is usually given every 2 or 4 weeks.

Common side effects of Cimzia include:

headache,

upper respiratory tract infection,

nausea,

diarrhea,

flu,

back pain,

stomach pain, and

pain in your extremities.

Tell your doctor if you have serious side effects of Cimzia including:

signs of infection (fever, chills, persistent sore throat),

shortness of breath,

fast or pounding heartbeats,

feeling dizzy or faint,

joint pain,

swelling of your feet or lower legs,

easy bruising or bleeding,

unusual weakness,

weight gain,

muscle pain or weakness,

confusion,

Increased thirst or urination,

fever,

skin rash, and

itching.

The recommended dose of Cimzia for RA is 200 mg given as two 100-mg injections under the skin once every 2 weeks for the first 4 weeks, followed by 200 mg given as one injection under the skin once every 4 weeks.

The recommended dose of Cimzia for CD is 400 mg given as two 200-mg injections under the skin once every 4 weeks. Your doctor may increase your dose

Cimzia (certolizumab pegol) is a biologic medication that works to treat autoimmune diseases. autoimmune diseases occur when your body’s immune system mistakenly attacks healthy cells and tissue.

Cimzia is what’s called a tumor necrosis factor (TNF) blocker. TNF is a protein that’s involved in the inflammatory response. By blocking TNF, cimzia can help reduce inflammation in your body.

Cimzia is used to treat:

Crohn’s disease

ulcerative colitis

psoriatic arthritis

ankylosing spondylitis

Cimzia is typically injected under the skin every other week. A healthcare provider will teach you how to inject cimzia at home.

Common side effects of cimzia include:

injection site reactions

headache

stomach pain

diarrhea

rash

flu-like symptoms

Cimzia can also increase your risk for serious infections. Tell your doctor if you have any symptoms of an infection, such as a fever, chills, or a sore throat.

Cimzia is a prescription medication. It’s available as a brand-name drug and a generic drug. Generic drugs usually cost less. In some cases, they may not be available in every strength or form as the brand-name version.

Cimzia may interact with other medications, vitamins, or herbs you may be taking. An interaction is when a substance changes the way a drug works. This can be harmful or prevent the drug from working well.

To help avoid interactions, your doctor should manage all of your medications carefully. Be sure to tell your doctor about all medications, vitamins, or herbs you’re taking. To find out how this drug might interact with something else you’re taking, talk to your doctor or pharmacist.

If you experience an serious side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online or by phone.

Cimzia (certolizumab pegol) is a prescription medication used to treat adults with Crohn's disease, plaque psoriasis, or ulcerative colitis. Crohn's disease and ulcerative colitis are inflammatory bowel diseases (IBD). Plaque psoriasis is a long-lasting, autoimmune disease that causes skin cells to grow too rapidly and form scales and itchy, dry patches.

Cimzia is a biologic medication. Biologic medications are derived from living cells cultured in a laboratory. They are used to treat a number of conditions, including Crohn's disease, plaque psoriasis, and ulcerative colitis.

Cimzia works by binding to a protein called tumor necrosis factor (TNF). TNF is a protein that is involved in the inflammation process. By binding to TNF, cimzia reduces the amount of TNF in the body. This helps to reduce the inflammation in the intestine, skin, or joints.

Cimzia is administered as an injection under the skin. The injection site can be the upper arm, thigh, or abdomen. Cimzia is given as an initial dose, followed by maintenance doses given every other week.

The most common side effects of cimzia include injection site reactions (redness, pain, swelling), upper respiratory tract infections, headache, and nausea. Cimzia can also cause serious side effects, including hepatitis B infection and serious allergic reactions.

Cimzia is a prescription medication used to treat adults with Crohn's disease, plaque psoriasis, or ulcerative colitis. Crohn's disease and ulcerative colitis are inflammatory bowel diseases (IBD). Plaque psoriasis is a long-lasting, autoimmune disease that causes skin cells to grow too rapidly and form scales and itchy, dry patches.

Cimzia is a biologic medication. Biologic medications are derived from living cells cultured in a laboratory. They are used to treat a number of conditions, including Crohn's disease, plaque psoriasis, and ulcerative colitis.

Cimzia works by binding to a protein called tumor necrosis factor (TNF). TNF is a protein that is involved in the inflammation process. By binding to TNF, cimzia reduces

Cimzia is a prescription medicine used to treat adults with certain autoimmune diseases. These diseases occur when your body’s own immune system attacks healthy cells and tissues.

Cimzia works by helping to decrease the activity of your body’s immune system. This can help to reduce the symptoms of your autoimmune disease.

Cimzia is a biologic medicine. Biologic medicines are made from living cells. They are different from most other medicines because they target specific parts of the immune system.

Cimzia is given as an injection under the skin. Your healthcare provider will teach you how to give yourself the injections.

Cimzia can cause serious side effects. These include:

• Infections. Cimzia can lower the ability of your immune system to fight infections. You may be more likely to get an infection or your infection may get worse. Tell your healthcare provider if you have any signs of an infection, such as a fever, chills, sweating, muscle aches, tiredness, cough, shortness of breath, diarrhea, weight loss, or local skin infections.

• Cancer. People who take Cimzia have an increased risk of developing cancer, especially certain types of lymphoma. Tell your healthcare provider if you have any new skin growths or changes in the appearance of existing skin growths.

• Reaction at the injection site. You may have redness, itching, swelling, or a lump under your skin where you inject Cimzia. These reactions usually happen within the first 2 weeks after you start injecting Cimzia.

• reactors. You may have a reaction to Cimzia if you are taking other medications. Be sure to tell your healthcare provider about all the medications you take, including over-the-counter medicines, Vitamins, herbal supplements, and any other prescription medicines.

• allergic reactions. Allergic reactions can happen with Cimzia. Tell your healthcare provider if you have any signs of an allergic reaction, such as hives, difficulty breathing, or swelling of your face, lips, tongue, or throat.

Cimzia is a prescription medicine used to treat adults with certain autoimmune diseases. These diseases occur when your body’s own immune system attacks healthy cells and tissues.

Cimzia works by helping to decrease the activity of your body

Cimzia is a biologic drug used to treat inflammatory conditions such as Crohn's disease, ulcerative colitis, and rheumatoid arthritis. It is a TNF-alpha inhibitor and works by reducing the production of this inflammatory protein. However, because it modifies the immune system's response, it can also leave patients vulnerable to infection. The most common side effects are related to the respiratory system, and include upper respiratory tract infection, sinusitis, and bronchitis. Other risks include gastrointestinal disorders such as diarrhea, headaches, and dizziness. In rare cases, cimzia has been linked to serious side effects such as liver damage, blood disorders, and nerve damage. Because of these potential risks, it is important that patients taking cimzia be closely monitored by their healthcare providers.

Cimzia (certolizumab) is a prescription medication used to treat Crohn’s disease. It is a man-made antibody that works by binding to a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in inflammation.

Cimzia is used in adults to treat Crohn’s disease, including active Crohn’s disease (which has flared up) and Crohn’s disease that is not responding to other medication. Cimzia is also used in adults to prevent Crohn’s disease from coming back after it has been treated.

Cimzia is different from other Crohn’s treatments because it is a biologic. Biologics are medications that are made from living cells. Other Crohn’s treatments are not biologics.

Cimzia is also different from other Crohn’s treatments because it is given as an injection. Other Crohn’s treatments can be given as a pill, a liquid, or an enema.

Cimzia is different from other Crohn’s treatments because it is given as an injection under the skin. Other Crohn’s treatments can be given as an injection into a vein or into a muscle.

Cimzia is different from other Crohn’s treatments because it is given once every two weeks. Other Crohn’s treatments can be given once a week, once a month, or less often.

Cimzia is different from other Crohn’s treatments because it can be used in combination with other Crohn’s treatments. Other Crohn’s treatments cannot be used in combination with other Crohn’s treatments.

Cimzia is different from other Crohn’s treatments because it may improve symptoms and help you stay in remission.

Cimzia (certolizumab pegol) is a biologic medication used to treat Crohn's disease and ulcerative colitis. Common side effects of Cimzia include: upper respiratory tract infection, headache, diarrhea, nausea, and injection site reactions (redness, pain, itching, swelling).

The most serious side effect of Cimzia is an increased risk for developing serious infections. This includes infections of the lungs, urinary tract, or intestines. Cimzia can also increase the risk for lymphoma. People with Crohn's disease or ulcerative colitis are already at an increased risk for developing these conditions.

Cimzia should not be used by people with an active infection, or who are at a high risk for developing an infection. People with a weakened immune system should also avoid Cimzia.

Talk to your doctor about the risks and benefits of Cimzia before starting treatment.

Cimzia (certolizumab) is a biologic medication used to treat autoimmune conditions such as Crohn's disease and ulcerative colitis. It works by targeting and binding to a protein called tumor necrosis factor (TNF), which plays a key role in inflammation. By binding to and neutralizing TNF, Cimzia can help reduce the inflammation and symptoms associated with Crohn's disease and ulcerative colitis.

Before starting Cimzia, you should talk to your doctor about the potential risks and benefits of the medication. You should also be aware of the possible side effects of Cimzia, which can include headaches, dizziness, diarrhea, and fatigue. If you have any other medical conditions, it's important to speak with your doctor to make sure that Cimzia is safe for you to take.

If you're starting Cimzia, be sure to follow your doctor's instructions carefully. You'll likely need to take the medication by injection, and it's important to use sterile technique to avoid infection. Cimzia is typically taken as two injections per week for the first four weeks, then one injection per week thereafter.

Maintaining good communication with your doctor is essential when taking Cimzia. Be sure to keep them updated on how you're feeling and if you're experiencing any side effects. With proper care and treatment, Cimzia can help you manage the symptoms of Crohn's disease or ulcerative colitis and improve your quality of life.